Sophie Bryant CCDC

Science is changing. The way that teams collaborate, the challenges faced, and the tools and resources available to scientists continue to change. At the CCDC several big changes are on the cards for 2021, to keep our data, software and services ready and relevant for our global user base.  

Advancing structural science, is advancing. 

New CSD-Theory software enables organisations to incorporate and share CSP data earlier and more easily, reducing risk and shortening the time to market for small molecule drug development.

The new CSD MOF Collection provides free access for academic research to 10,636 metal—organic framework crystal structures.

For this year's #WomenInScience day we celebrate all the amazing women who have made great science happen with the CCDC over the past year.

The journal CrystEngComm has published a special issue to mark the Cambridge Structural Database (CSD) reaching 1 million structures, with 33 papers that highlight the breadth of applications made possible with this data.

Hundreds of people have joined the CCDC and BACG at the Crystal Conversations virtual events this year - for tutorials, talks and tea breaks for solid form scientists of all disciplines. This month we built a community toolkit of resources that help you do great work.

Announcing the challenge

This week the 7th CSP Blind Test begins - a major challenge in computational chemistry. It will see the world leading methods in Crystal Structure Prediction put to the test on real targets - with a high bar set by previous work. The 7 test systems have been sourced from leading experimentalists in industry and academia for prediction.

The September Crystal Conversations meeting included a Careers Clinic session. Attendees asked our panel of 6 professionals questions about career options, progression and advice for the future of jobs in STEM.

The BioChemGRAPH collaboration brings together key chemical and biochemical datasets, to give researchers deeper insights than ever before.

As the corona virus (COVID-19) pandemic continues, scientists around the world have set up virtual projects to collaborate, share knowledge, resources and data to support drug discovery.